PDE12
Basic information
Region (hg38): 3:57556274-57656480
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE12 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 32 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 1 | 0 |
Variants in PDE12
This is a list of pathogenic ClinVar variants found in the PDE12 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-57556410-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
3-57556480-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
3-57556506-G-C | not specified | Uncertain significance (May 08, 2024) | ||
3-57556561-A-G | not specified | Uncertain significance (Jan 17, 2024) | ||
3-57556566-A-G | not specified | Uncertain significance (May 24, 2023) | ||
3-57556585-A-C | not specified | Uncertain significance (Nov 30, 2022) | ||
3-57556614-G-A | not specified | Uncertain significance (Feb 14, 2024) | ||
3-57556621-A-G | not specified | Uncertain significance (Apr 26, 2023) | ||
3-57556632-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
3-57556660-A-G | not specified | Uncertain significance (Feb 01, 2023) | ||
3-57556758-T-G | not specified | Uncertain significance (Dec 20, 2023) | ||
3-57556761-C-G | not specified | Uncertain significance (Nov 02, 2023) | ||
3-57556878-C-G | not specified | Uncertain significance (Feb 27, 2024) | ||
3-57556882-A-G | not specified | Uncertain significance (Dec 03, 2021) | ||
3-57556894-A-G | not specified | Uncertain significance (Aug 11, 2022) | ||
3-57557083-A-G | not specified | Uncertain significance (Feb 28, 2024) | ||
3-57557107-G-C | not specified | Uncertain significance (Jan 31, 2024) | ||
3-57557139-G-A | not specified | Likely benign (Dec 27, 2023) | ||
3-57557212-C-A | not specified | Uncertain significance (Mar 16, 2022) | ||
3-57557312-G-T | not specified | Uncertain significance (Sep 16, 2021) | ||
3-57557343-G-C | not specified | Uncertain significance (May 08, 2023) | ||
3-57557374-A-G | not specified | Uncertain significance (Nov 10, 2021) | ||
3-57557464-T-G | not specified | Uncertain significance (May 09, 2022) | ||
3-57557556-C-T | not specified | Uncertain significance (Feb 06, 2024) | ||
3-57557590-C-T | not specified | Uncertain significance (Feb 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDE12 | protein_coding | protein_coding | ENST00000311180 | 3 | 10569 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0444 | 0.955 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.40 | 268 | 340 | 0.787 | 0.0000159 | 3947 |
Missense in Polyphen | 51 | 71.491 | 0.71338 | 837 | ||
Synonymous | 0.818 | 130 | 142 | 0.913 | 0.00000696 | 1268 |
Loss of Function | 2.87 | 6 | 19.8 | 0.303 | 9.02e-7 | 240 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000252 | 0.000242 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000133 | 0.000132 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Enzyme that cleaves 2',5'-phosphodiester bond linking adenosines of the 5'-triphosphorylated oligoadenylates, triphosphorylated oligoadenylates referred as 2-5A modulates the 2-5A system. This enzyme degraded triphosphorylated 2-5A to produce AMP and ATP. Also cleaves 3',5'-phosphodiester bond of oligoadenylates. Plays a role as a negative regulator of the The 2-5A system that is one of the major pathways for antiviral and antitumor functions induced by interferons (IFNs). Suppression of this enzyme induces reduction of viral replication in Hela cells, thus counteracting the antiviral pathway probably by inhibiting the 2-5A system. {ECO:0000269|PubMed:15231837, ECO:0000269|PubMed:21245038, ECO:0000269|PubMed:21666256, ECO:0000269|PubMed:22285541}.;
- Pathway
- Phosphodiesterases in neuronal function
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.403
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.36
Haploinsufficiency Scores
- pHI
- 0.0844
- hipred
- N
- hipred_score
- 0.463
- ghis
- 0.644
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.850
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pde12
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;mitochondrial mRNA catabolic process;mRNA processing;cellular response to interferon-alpha;regulation of mitochondrial mRNA stability;positive regulation of viral genome replication;defense response to virus;negative regulation of cell death;cellular response to interferon-gamma;cellular response to dsRNA;nucleic acid phosphodiester bond hydrolysis;negative regulation of oxidative phosphorylation;RNA phosphodiester bond hydrolysis, exonucleolytic
- Cellular component
- mitochondrial matrix;cytosol
- Molecular function
- 3'-5'-exoribonuclease activity;exonuclease activity;poly(A)-specific ribonuclease activity;oligoribonucleotidase activity;metal ion binding